During the past decade, Hartford Hospital Cancer Clinical Research Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hartford Hospital Cancer Clinical Research Office" are "Hemoglobinuria, Paroxysmal" (2 trials), "Cachexia" (1 trials) and "Paroxysmal Hemoglobinuria, Nocturnal" (1 trials). Many other conditions were trialed in "Hartford Hospital Cancer Clinical Research Office" in a lesser frequency.

Most popular intervention types in "Hartford Hospital Cancer Clinical Research Office" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "eculizumab" (3 trials), "GTx-024" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hartford Hospital Cancer Clinical Research Office" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hartford Hospital Cancer Clinical Research Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hartford Hospital Cancer Clinical Research Office, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hartford Hospital Cancer Clinical Research Office, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".